Balancing the benefits and harms of oral anticoagulation in non-valvular atrial fibrillation

被引：1
|
作者：
Lindley, Richard, I [1 ,2 ]
机构：
[1] Univ Sydney, Fac Med & Hlth, Westmead Appl Res Ctr, Camperdown, NSW, Australia
[2] George Inst Global Hlth, Sydney, NSW, Australia
来源：
AUSTRALIAN PRESCRIBER | 2021年 / 44卷 / 02期
关键词：
anticoagulants; apixaban; atrial fibrillation; dabigatran; haemorrhage; rivaroxaban; thromboembolism;
D O I：
10.18773/austprescr.2021.002
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Non-valvular atrial fibrillation is becoming more common in Australia and globally. The direct oral anticoagulants apixaban, dabigatran and rivaroxaban offer an improved safety profile over warfarin. Patient preferences are important and shared decision-making supports better adherence to treatment.
引用
收藏
页码：49 / 52
页数：4
相关论文
共 50 条
  • [21] Timing of Anticoagulation After Stroke in Patients with Non-Valvular Atrial Fibrillation
    Sagalovich, Marina
    Osteraas, Nicholas
    Glover, Jon
    Dafer, Rima
    [J]. NEUROLOGY, 2021, 96 (15)
  • [22] Prescribers' perceptions of benefits and limitations of direct acting oral anticoagulants in non-valvular atrial fibrillation
    Generalova, Daria
    Cunningham, Scott
    Leslie, Stephen J.
    Rushworth, Gordon F.
    Mciver, Laura
    Stewart, Derek
    [J]. PHARMACY PRACTICE-GRANADA, 2020, 18 (02): : 1 - 6
  • [23] Quality of oral anticoagulation control in Chinese patients with non-valvular atrial fibrillation: a prospective controlled study
    Li, Yaqian
    Yu, Jingjing
    Kuang, Yun
    Wu, Chengkun
    Yang, Liu
    Fang, Qiulian
    Pei, Qi
    Yang, Guoping
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (09) : 1433 - 1439
  • [24] Warfarin in non-valvular atrial fibrillation
    Dalby, A. J.
    Wessels, P.
    Opie, L. H.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2013, 103 (12): : 901 - 904
  • [25] Comparison Between Oral Anticoagulation and Left Atrial Appendage Occlusion in the Prevention of Stroke With Regard to Non-Valvular Atrial Fibrillation
    Sandhu, Osama
    Aftab, Zarmeena
    Anthony, Adarsh Thomas
    Rahmat, Shermeen
    Khan, Safecra
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (09)
  • [26] Characteristics of non-valvular atrial fibrillation with left atrial appendage thrombus who are undergoing appropriate oral anticoagulation therapy
    Shiraki, Hiroaki
    Tanaka, Hidekazu
    Yamauchi, Yuki
    Yoshigai, Yuko
    Yamashita, Kentaro
    Tanaka, Yusuke
    Sumimoto, Keiko
    Shono, Ayu
    Suzuki, Makiko
    Yokota, Shun
    Matsumoto, Kensuke
    Fukuzawa, Koji
    Hirata, Ken-ichi
    [J]. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2022, 38 (05): : 941 - 951
  • [27] Asymptomatic embolisation in non-valvular atrial fibrillation and its relationship to anticoagulation therapy
    Tinkler, Kerry
    Cullinane, Marisa
    Kaposzta, Zoltan
    Markus, Hugh S.
    [J]. European Journal of Ultrasound, 2002, 15 (1-2) : 21 - 27
  • [28] Impact of Frailty in Non-Valvular Atrial Fibrillation Elderly Patients on Anticoagulation Therapy
    Matsui, Kunihiko
    Kusano, Kengo F.
    Akao, Masaharu
    Tsuji, Hikari
    Hiramitsu, Shinya
    Hatori, Yutaka
    Odakura, Hironori
    Ogawa, Hisao
    [J]. CIRCULATION, 2023, 148
  • [29] Application of a decision support tool for anticoagulation in patients with non-valvular atrial fibrillation
    Wess, Mark L.
    Schauer, Daniel P.
    Johnston, Joseph A.
    Moomaw, Charles J.
    Brewer, David E.
    Cook, E. Francis
    Eckman, Mark H.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 (04) : 411 - 417
  • [30] Factors Associated with Anticoagulation Adherence in Chinese Patients with Non-Valvular Atrial Fibrillation
    Song, Ting
    Xin, Xiao
    Cui, Peirong
    Zong, Mingcan
    Li, Xianhua
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2021, 15 : 493 - 500
12345